NCT07293221 Immersive Virtual Reality for the Management of Anxiety Among Nurses
| NCT ID | NCT07293221 |
| Status | Recruiting |
| Phase | — |
| Sponsor | SCP Anesthésie - Réanimation de la Clinique du Pont de Chaume |
| Condition | Anxiety |
| Study Type | INTERVENTIONAL |
| Enrollment | 56 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 56 participants in total. It began in 2026-03-01 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The nursing profession is recognized as one of the most demanding in the healthcare sector. Constant exposure to illness, suffering, and death, combined with an increasing workload, leads to fatigue, stress, and especially persistent anxiety. This anxiety affects not only the psychological and physical health of nurses but also the quality of care provided. From an organizational perspective, anxiety promotes absenteeism, demotivation, and turnover, creating a vicious cycle of collective exhaustion. To relieve their anxiety, an increasing number of healthcare providers are turning to complementary medicine, particularly immersive virtual reality (VR) interventions. Immersive VR hypnosis has been used for several years as a non-pharmacological approach to anxiety management. It constitutes a relational experience engaging both physiological and psychological mechanisms, allowing the user to improve their experience and reduce or even eliminate anxiety. Randomized clinical trials conducted in recent years have evaluated the efficacy of immersive VR hypnosis. Some results indicate that it reduces anxiety more significantly than pharmacological treatments in control groups and is at least as effective as other complementary therapies (relaxation, massage, acupuncture, yoga, etc.). However, the strength of these conclusions remains limited due to a substantial risk of methodological bias. Rigorous new studies, with strict control conditions, are required, particularly regarding the efficacy of hypnosis applied to nurses. Since 2024, the investigators have offered hypnotic VR sessions to nurses at the Clinique du Pont de Chaume to better manage their anxiety. Despite the high satisfaction rate reported in our questionnaires, the investigators now aim to statistically evaluate the efficacy of this intervention. Ultimately, these results could justify a broader investment in this type of equipment, making it available to a larger number of healthcare professionals but only if this complementary intervention demonstrates scientific efficacy.
Eligibility Criteria
Inclusion Criteria: Nurses who have received appropriate information, agreed to participate, and signed the informed consent form. Nurses working day shifts (06:00-18:00) with a coffee break scheduled from 09:00 to 09:15. Exclusion Criteria: Nurses who have not provided informed consent or cannot comply with the study protocol. History of photosensitive epilepsy or seizures. Unstable vestibular disorders or a severe history of motion sickness preventing the use of immersive VR. Employer refusal if participation cannot be organized outside work obligations (participation must remain voluntary and without professional consequences).
Contact & Investigator
Edmundo P PEREIRA DE SOUZA NETO, Phd
PRINCIPAL INVESTIGATOR
Clinique du Pont de Chaume - Montauban
Frequently Asked Questions
Who can join the NCT07293221 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07293221 currently recruiting?
Yes, NCT07293221 is actively recruiting participants. Contact the research team at edmundo.pereira-de-souza@hotmail.fr for enrollment information.
Where is the NCT07293221 trial being conducted?
This trial is being conducted at Montauban, France.
Who is sponsoring the NCT07293221 clinical trial?
NCT07293221 is sponsored by SCP Anesthésie - Réanimation de la Clinique du Pont de Chaume. The principal investigator is Edmundo P PEREIRA DE SOUZA NETO, Phd at Clinique du Pont de Chaume - Montauban. The trial plans to enroll 56 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.